Related references
Note: Only part of the references are listed.MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
Yi Wang et al.
SCIENCE ADVANCES (2021)
The inflammatory speech of fibroblasts
Ronen Schuster et al.
IMMUNOLOGICAL REVIEWS (2021)
C-C Motif Chemokine Ligand-17 as a Novel Biomarker and Regulator of Epithelial Mesenchymal Transition in Renal Fibrogenesis
Yi-Hsien Hsieh et al.
CELLS (2021)
Fibroblasts: Origins, definitions, and functions in health and disease
Maksim Plikus et al.
CELL (2021)
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis
Shan-Shan Liu et al.
IMMUNITY (2021)
TRIB3-GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target
Shanshan Liu et al.
ACTA PHARMACEUTICA SINICA B (2021)
Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis
Pitchumani Sivakumar et al.
RESPIRATORY RESEARCH (2021)
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas
Donald C. Moore et al.
ANNALS OF PHARMACOTHERAPY (2020)
Transforming growth factor-beta in tissue fibrosis
Nikolaos G. Frangogiannis
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: safety and efficacy
Daniel J. Lewis et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Peter M George et al.
Lancet Respiratory Medicine (2020)
Update in Pulmonary Fibrosis 2018
Giacomo Sgalla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
Adi Mor et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages
Shan-shan Liu et al.
IMMUNITY (2019)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Benjamin Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice
Kazuhiko Matsuo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sezary Syndrome
Julia Dai et al.
JAMA DERMATOLOGY (2018)
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Chiara Berlato et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
CHEST (2016)
CCR4 and its ligands: from bench to bedside
Osamu Yoshie et al.
INTERNATIONAL IMMUNOLOGY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
CCL17 Promotes Intestinal Inflammation in Mice and Counteracts Regulatory T Cell-Mediated Protection From Colitis
Alexander F. Heiseke et al.
GASTROENTEROLOGY (2012)
Phenotypic characterization of lung macrophages in asthmatic patients: Overexpression of CCL17
Karl J. Staples et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis
Katrin Palumbo et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis
Jette L. Riis et al.
EXPERIMENTAL DERMATOLOGY (2011)
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
Christian Weber et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Helene Aarslev Flytlie et al.
CYTOKINE (2010)
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Antje Prassel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Purevdorj B. Olkhanud et al.
CANCER RESEARCH (2009)
Elevated CC Chemokine Level in Bronchoalveolar Lavage Fluid Is Predictive of a Poor Outcome of Idiopathic Pulmonary Fibrosis
Hiromi Shinoda et al.
RESPIRATION (2009)
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
Yurika Yogo et al.
RESPIRATORY RESEARCH (2009)
Chemotaxis, chemokine receptors and human disease
Tian Jin et al.
CYTOKINE (2008)
Chemokines and leukocyte traffic
Federica Sallusto et al.
NATURE IMMUNOLOGY (2008)
CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors
Dolgor Baatar et al.
JOURNAL OF IMMUNOLOGY (2007)
CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli
Yuichiro Tsunemi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Elevation of macrophage-derived chemokine in eosinophilic pneumonia : a role of alveolar macrophages
Kazuyoshi Manabe et al.
JOURNAL OF MEDICAL INVESTIGATION (2005)
CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis
T Inoue et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
The role of the Th2CC chemokine ligand CCL17 in pulmonary fibrosis
JA Belperio et al.
JOURNAL OF IMMUNOLOGY (2004)
IFN-γ-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis
T Horikawa et al.
INTERNATIONAL IMMUNOLOGY (2002)
Share Paper
